This document discusses guidelines for applying bracketing and matrixing designs to stability testing as outlined in ICH Q1A. Bracketing involves testing only the extremes of design factors like strength, while assuming stability of intermediates is represented by the extremes. Matrixing involves testing selected samples of all combinations at time points. Reduced designs can shorten testing if justified based on supporting data variability and product stability. However, reduced designs may underestimate shelf life compared to full testing and miss some degradation interactions. Data from reduced designs should still be evaluated statistically.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
Analytical method qualification consists of a simplified evaluation of a subset of validation characteristics with a goal to demonstrate that an analytical method is scientifically sound and suitable for its intended use. In contrast to validation, analytical method qualification is performed without predefined acceptability criteria. Qualification may be performed as a prerequisite to method validation, or when an assay for product knowledge has not yet been established as a test for a critical product quality attribute. Qualification of equipment is pre-requisite for validation of the process in which the equipment is being used. Many types of equipment have measuring devices on them. Calibration of measuring devices is a part of qualification. Calibration of measuring devices is important, as the data is often collected through them. If the data collected is not from measuring devices that have been calibrated, the data cannot be relied upon. Thus the whole validation exercise can be questioned.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
2 Aspects of compatibility tests are:
Identification of compatible excipients for a formulation.
Identification of stable storage conditions
2 Types:
Solid state reactions: much slower and difficult to interpret.
Liquid state reactions: easier to detect
According to Stability Guidelines by FDA following conditions should be evaluated for solutions or suspensions
1. Acidic or alkaline pH.
2. Presence of added substances
3. High oxygen and nitrogen atmospheres.
4. Effect of stress testing conditions.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
Analytical method qualification consists of a simplified evaluation of a subset of validation characteristics with a goal to demonstrate that an analytical method is scientifically sound and suitable for its intended use. In contrast to validation, analytical method qualification is performed without predefined acceptability criteria. Qualification may be performed as a prerequisite to method validation, or when an assay for product knowledge has not yet been established as a test for a critical product quality attribute. Qualification of equipment is pre-requisite for validation of the process in which the equipment is being used. Many types of equipment have measuring devices on them. Calibration of measuring devices is a part of qualification. Calibration of measuring devices is important, as the data is often collected through them. If the data collected is not from measuring devices that have been calibrated, the data cannot be relied upon. Thus the whole validation exercise can be questioned.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
2 Aspects of compatibility tests are:
Identification of compatible excipients for a formulation.
Identification of stable storage conditions
2 Types:
Solid state reactions: much slower and difficult to interpret.
Liquid state reactions: easier to detect
According to Stability Guidelines by FDA following conditions should be evaluated for solutions or suspensions
1. Acidic or alkaline pH.
2. Presence of added substances
3. High oxygen and nitrogen atmospheres.
4. Effect of stress testing conditions.
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
Abbreviated New Drug Application [ANDA]Sagar Savale
An Abbreviated New Drug Application (ANDA) contains data which when submitted to FDA's CDER, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.
What is COPPs? How to apply for COPPs (Certificate of Pharmaceutical Products)?Ajay kamboj
CoPP is necessary for exporting medicines and pharmaceutical products from India. The application for grant of WHO GMP Certificate of Pharmaceutical Product shall be made to respective zonal/sub zonal officers appointed by DCGI as per the requirement.
QUALIFICATION & VALIDATION.Validation is an essential part of GMP, and an element of QA.Critical steps in the process need to be validated.Need for confidence that the product will consistently meet predetermined specifications and attributes.
In this presentation I have mentioned whatever the possible relevant content/guidelines require for biowaiver application.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
Bracketing and matrixing designs (Q1D) AISSMS College Of PharmacyAISSMS
Read an interesting information about Bracketing and Matrixing designs for stability testing of new drug substances and products by AISSMS College Of Pharmacy.
Change control is a formal system by which qualified representatives of appropriate disciplines review proposed or actual changes that might effect a validated status. The intent is to determine the need for the action that would ensure that the system is maintained in a validated state.
Abbreviated New Drug Application [ANDA]Sagar Savale
An Abbreviated New Drug Application (ANDA) contains data which when submitted to FDA's CDER, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product.
What is COPPs? How to apply for COPPs (Certificate of Pharmaceutical Products)?Ajay kamboj
CoPP is necessary for exporting medicines and pharmaceutical products from India. The application for grant of WHO GMP Certificate of Pharmaceutical Product shall be made to respective zonal/sub zonal officers appointed by DCGI as per the requirement.
QUALIFICATION & VALIDATION.Validation is an essential part of GMP, and an element of QA.Critical steps in the process need to be validated.Need for confidence that the product will consistently meet predetermined specifications and attributes.
In this presentation I have mentioned whatever the possible relevant content/guidelines require for biowaiver application.
Citation Is done at the end of slide.
Content is up to date & true to my belief.
Thanks & Best Regards.
Anurag Pandey
B.Pharm (FACULTY OF PHARMACY, INVERTIS UNIVERSITY)
M.Pharm (INSTITUTE OF PHARMACY, NIRMA UNIVERSITY)
Email :- anurag.dmk05@gmail.com
PIC/S is a combine term used for the execution of activities of Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
harmonize, educate, and update aspects relating to Good Manufacturing Practice among member countries
harmonized relation among regulatory authorities and governments
members
history
role
objective and function
guidlines
Bracketing and matrixing designs (Q1D) AISSMS College Of PharmacyAISSMS
Read an interesting information about Bracketing and Matrixing designs for stability testing of new drug substances and products by AISSMS College Of Pharmacy.
Shivam Dubey Pharmaceutics Assignment 03: ICH Guidelines On Drug StudiesMrHotmaster1
Sedatives & Hypnotics
Sedatives
➢ It is a drug that reduces excitement and calms the person
➢ A drug that reduces excitement, calms the patient (without inducing sleep)
➢ Sedatives in therapeutic doses are anxiolytic agents
➢ Most sedatives in larger doses produce hypnosis (trans like state in which
subject becomes passive and highly suggestible)
Adaptive clinical trials have risen in popularity and gained more attention since the FDA Critical Path Initiative (2004) and Critical Path Opportunity List (2006) called for innovative solutions to transform the way medicinal products are developed, evaluated, and manufactured. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
ICH Guideline Stability Testing of New Drug Substances and Product Q1A(R2).pptxTrishala Bhatt
This presentation outlines the ICH Guideline for Stability Testing of New Drug Substances and Products, Q1A(R2). It serves as a comprehensive framework for ensuring the stability of new pharmaceuticals, with a focus on the requirements for registration applications within the EC, Japan, and the United States. The guideline emphasizes a balance between a standardized approach and the flexibility to adapt to specific scientific considerations and characteristics of the materials under evaluation.
Advances in Clinical Trial Design: Adaptive and Platform TrialsClinosolIndia
Advances in clinical trial design have led to the emergence of two innovative approaches: adaptive trials and platform trials. These designs offer flexibility, efficiency, and the potential to accelerate the development of new therapies.
Adaptive Trials:
Adaptive trials are designed to make real-time modifications to key aspects of the study, such as the sample size, treatment arms, or patient population, based on accumulating data during the trial. This adaptive approach allows researchers to make informed decisions and optimize the trial design as new information becomes available. Adaptive trials can be particularly beneficial when studying complex diseases or evaluating treatments with varying responses.
Advances in Clincal Trial Design- Adaptive and Platform TrialsClinosolIndia
Adaptive designs can make clinical trials more flexible by utilising results accumulating in the trial to modify the trial’s course in accordance with pre-specified rules. Trials with an adaptive design are often more efficient, informative and ethical than trials with a traditional fixed design since they often make better use of resources such as time and money, and might require fewer participants. Adaptive designs can be applied across all phases of clinical research, from early-phase dose escalation to confirmatory trials. The pace of the uptake of adaptive designs in clinical research, however, has remained well behind that of the statistical literature introducing new methods and highlighting their potential advantages.
Adaptive Clinical Trials: Enhancing Precision and EfficiencyClinosolIndia
Adaptive clinical trials represent a transformative approach to clinical research, offering unparalleled flexibility, efficiency, and precision. As the scientific community continues to embrace adaptive designs, the landscape of clinical trials is evolving to better meet the challenges of modern drug development. The integration of adaptive methodologies holds the promise of not only expediting the path to effective treatments but also ensuring that the trial process is patient-centered, resource-efficient, and responsive to the dynamic nature of medical research.
Similar to BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS (Q1D) (20)
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS (Q1D)
1. PRESENTED BY: Mrunal More
M.Pharmacy (Pharmaceutics)
AISSMS College of Pharmacy
Pune-411001
1
2. INTRODUCTION
APPLICABILITY OF THE REDUCED DESIGNS
BRACKETING
MATRIXING
DATA EVALUATION
SUMMARY
REFERENCES
BONUS
CONTENTS
2
3. 1.International Conference of Harmonisation of technical requirements for
registration of pharmaceuticals for human use.
2. ICH Topics are divided into four categories :
ICH
3
4. 1. Q1A(R2)-Stability testing for new drug substances and
products.
2. Q1B - Stability testing: Photo stability testing of new
drug substances and products.
3. Q1C - Stability testing for new dosage forms.
4. Q1D - Bracketing and Matrixing designs for stability
testing of new drug substances and products.
5. Q1E - Evaluation of stability data.
6. Q1F- Stability data package for Registration applications
in Climatic zones III and IV
Q1 - STABILITY
4
5. 1.1 Objectives of the Guideline
This guideline is intended to address recommendations on the application of
bracketing and matrixing to stability studies conducted in accordance with
principles outlined in the ICH Q1A(R) Harmonised Tripartite guideline on Stability
Testing of New Drug Substances and Products (hereafter referred to as the parent
guideline).
1.2 Background
The parent guideline notes that the use of matrixing and bracketing can be
applied,if justified,to the testing of new drug substances and products, but provides
no further guidance on the subject.
1.3 Scope of the Guideline
This document provides guidance on bracketing and matrixing study designs.
Specific principles are defined in this guideline for situations in which bracketing or
matrixing can be applied. Sample designs are provided for illustrative purposes,
and should not be considered the only, or the most appropriate, designs in all
cases.
INTRODUCTION
5
6. These are reduced designs in which all samples are not
tested at all time points.
Alternatively used when multiple design factors are
involved.
Certain assumptions should be made and justified.
Potential risk should be considered before assuming the
shorter retest period and shelf life.
A change from full to reduced test design should be
considered, if the justification is done and principles of both
the designs are followed.
During the test study, once the design is changed from the
full to reduced it should be carried out through the
remaining study.
6
7. It can be applied for drug products,but additional
justification should be done for some complex substances
which have potential drug-device reaction.
Whether bracketing or matrixing should be done, decided as
per the conditions.
Data variability and product stability shown by the
supporting data should be considered for the application of
matrixing design.
Careful consideration and scientific justification should be
there in selection of designs.
Applicability of the Reduced designs
7
8. In this the samples in the extremes of design factors are
only tested at all time points.
It assumes that the stability of the intermediates is
represented by the stability of the extremes tested.
The use of this design is inappropriate if the selected
samples are not the extremes.
Design factors: These are variables which should be
evaluated for their effect on stability. They are:
1. Strength
2. Container size or fill
Bracketing
8
9. Applied for multiple strengths and closely related
formulations.
Examples:
a) Capsules - different fill plug sizes and strengths,
made up of same powder blend.
b) Tablets - different strengths manufactured with
compressing varying amounts of same granulation.
c) Oral solutions - different strengths which may differ
in minor excipients (colorants, flavourings) (pic)
If different excipients are used among strengths,
bracketing should not be applied.
STRENGTH
9
10. Either fill size or container size should be vary and other
should be constant.
If both are varying, the smallest and largest are not
considered as the extremes of the packaging operations.
In selecting the extremes, compare the characters carefully
because it may effect the stability of the product.
The characters include container wall thickness, surface to
volume ratio, oxygen permeation rate per dosage unit,
closure geometry.
It is applied for the same container having different
closures with justification.
Container size or fills
10
11. During the study, if one of the extreme is known to be no
longer in the market, then design is made for supporting
the intermediates.
Retest period and shelf life should be assessed before
applying this design.
If the stabilities of both the extremes are different, then
the stability of the intermediate will be considered as not
more than the least stable extreme.
The shelf life of the intermediates will be less than the
shelf life of the least stable extreme.
Design consideration and Potential Risk
11
13. It is the stability schedule in which selected samples
for all combinations are tested at a time point.
At subsequent time point, another set of samples of all
combinations are tested.
This design assumes that the stability of each set of
samples represents the stability of the remaining
samples at a given point.
The differences in the same drug sample are different
strengths, different batches, different sizes of the same
container closure system.
When secondary packaging system contributes to the
stability of the system, then packaging materials should
be tested.
MATRIXING
13
14. This design can be applied for different strengths of
identical or closely related substances. Examples are
a) Capsules - different fill plug sizes and strengths,
made up of same powder blend.
b) Tablets - different strengths and compressed with
varying amounts of same granulation.
c) Oral solutions - different strengths which may
differ in minor excipients.
d) Different batches made by same process and same
equipment.
Justification should be done based on supporting data.
DESIGN FACTORS
14
15. In this design, each sample should be tested at intended
time points and should be tested at last time point before
the submission.
Because it is difficult to test at all time points as in full test,
some time points are matrixed.
It should be tested for first and last time points for selected
factors, but for some factors intermediate time points
should also be tested.
For accelerated or intermediate storage condition testing,
atleast three points should be tested.
Design ConsiderationS
15
16. Table 2: Examples of Matrixing Designs on Time Points for a
product with two strengths One half reduction
Design example
16
Total= 48
½= 24
Reduced =15
18. The one half reduction in which one in two time points is
eliminated from testing.
The one third reduction in which one in three time points is
eliminated from testing.
These examples include the full testing for the initial, final
and 12 month time period points.
In one half reduction, the time points are reduced less than
the one half (24/48) that is actually (15/48).
In one third reduction, the time points are reduced less than
the one third (16/48) that is actually (10/48).
18
19. The following should be followed when matrixing is applied:
• knowledge of data variability
• availability of supporting data
• stability differences in the product within a factor or among
factors
• number of factor combinations in the study
In general matrixing is done when the appropriate supporting
data indicate appropriate product stability.
If the variability in the supporting data is less and moderate
matrixing can be done.
If the variability is high matrixing cannot be done.
contd…
Applicability and Degree of reduction
19
20. The matrixing design can be justified with respect to its
power to detect differences among factors of degradation
and its precision in shelf life estimation.
If the design is applicable, the degree of reduction depends
on the number of factors involved.
The more the factors involved, the more the degree of the
reduction.
Any design should have the ability to calculate the shelf life
of a product appropriately.
20
21. Due to the insufficient data collected for the testing, the
matrixing design may get lesser shelf life than the shelf life
got from the full test design.
That matrixing design has lesser efficiency to detect certain
interaction effects leading to incorrect pooling of data.
If testing of factor combinations is reduced, the tested
factor combinations cannot give sufficient data for finding
the shelf life.
Potential Risk
21
22. Data Evaluation
The data collected from the reduced design should be
treated in the same manner as collected from the full test
design by using statistical applications.
22
23. The reduced test designs are used for the testing the
stability in lesser time than the full test design by
considering some risks.
Bracketing design in which extremes are tested and
Matrixing design in which selected samples are tested.
Bracketing is mainly used to pursue a trend initially in pre
clinical studies and clinical trials. Matrixing is used to
confirm a prediction of the stability information.
The reduced designs should be used after the proper
justification and scientific consideration.
They may not get precise shelf life values as the full test
design.
CONCLUSION
23
24. BRACKETING AND MATRIXING DESIGNS FOR STABILITY
TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS Q1D
: ICH Harmonised Tripartite Guideline, current step 4
version, 7 February 2002, page no: 1-7.
https://www.youtube.com/watch?v=Np6ulndf78Q
REFERENCE
24